Curable in early stages, colorectal cancer is the second leading cause of cancer mortality. While GI cancers are still a disease of aging, the increased incidence of colorectal cancers in younger patients has prompted a change in current screening age recommendations. The session will discuss the high-risk populations that require colonoscopy and the importance of other tools like family history and physical exams. In addition, the presenter will discuss how certain patients can benefit from immunotherapy, rather than standard chemotherapy.
- Identify the appropriate screening methods for different patient types
- Recognize the clinical signs that support early detection
- Review therapies for GI cancer